Fitbit's Final Days?
In this episode of MarketFoolery, host Chris Hill and Aaron Bush analyze the lone bright spot on Fitbit's (NYSE: FIT) balance sheet, although this may be the beginning of the end. Meanwhile, shares of data analytics software company Alteryx (NYSE: AYX) rise another 10%, while shares of medical device maker Abiomed (NASDAQ: ABMD) fall more than 20%. Plus, Chris and Aaron discuss the current landscape of esports and potential investments in this growing industry.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.
Source Fool.com
